X
26Aug

Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla

Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By: Robins Kaplan LLP
Source Url: https://www.jdsupra.com/legalnews/financial-daily-dose-8-26-2019-top-43922/

Related

Class Action Decertified for Lack of Standing

A judge in the U.S. District Court for the Central District of California recently granted a defenda...

Read More >

Diving Into OFCCP’s Construction Contractor Technical Assistance Guide

The recently updated Construction Contractors Technical Assistance Guide (“TAG”) provides construc...

Read More >

COVID-19 Relief: Paycheck Protection Program and Issues in M&A Transactions

Potential merger partners of and investors in businesses that have received loans under the Paycheck...

Read More >

Newsletter sociale - Octobre 2019

Nous vous proposons, dans cette newsletter, de revenir sur les nouvelles règles applicables au détac...

Read More >

[Video] Sitting with the C-Suite: Managing the Merger and Looking Toward the Future

On Monday, August 17, 2020, Baker Donelson's Clinton Sanko sat down with Wendell Jisa, CEO of Reveal...

Read More >

[Video] Virtual Care 2.0: The Future of Digital Health

Rock Health called the landmark Teladoc-Livongo deal a starter pistol for the virtual care platform ...

Read More >